These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24775617)

  • 1. Low clinical penetrance in causal mutation carriers for cardiac channelopathies.
    Jiménez-Jáimez J; Álvarez M; Algarra M; Macías Ruíz R; Peñas R; Valverde F; Tortajada G; Lorente JA; Melgares R; Tercedor L
    Rev Esp Cardiol (Engl Ed); 2013 Apr; 66(4):275-81. PubMed ID: 24775617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sudden death and ion channel disease: pathophysiology and implications for management.
    Bastiaenen R; Behr ER
    Heart; 2011 Sep; 97(17):1365-72. PubMed ID: 21685181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Postmortem genetic testing in sudden cardiac death due to ion channelopathies].
    Guan DW; Zhao R
    Fa Yi Xue Za Zhi; 2010 Apr; 26(2):120-7. PubMed ID: 20653139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetic and clinical features of cardiac channelopathies.
    Roberts JD; Gollob MH
    Future Cardiol; 2010 Jul; 6(4):491-506. PubMed ID: 20608822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sudden cardiac death and genetic ion channelopathies: long QT, Brugada, short QT, catecholaminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation.
    Napolitano C; Bloise R; Monteforte N; Priori SG
    Circulation; 2012 Apr; 125(16):2027-34. PubMed ID: 22529064
    [No Abstract]   [Full Text] [Related]  

  • 6. Sudden infant death syndrome: do ion channels play a role?
    Van Norstrand DW; Ackerman MJ
    Heart Rhythm; 2009 Feb; 6(2):272-8. PubMed ID: 18823823
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic Approach to Unexplained Cardiac Arrest (from the FIVI-Gen Study).
    Jiménez-Jáimez J; Peinado R; Grima EZ; Segura F; Moriña P; Sánchez Muñoz JJ; Mazuelos F; Cózar R; Gimeno JR; Heras RP; Monserrat L; Domingo D; Ortiz-Genga M; Fernández Pastor J; Álvarez M; Tercedor L
    Am J Cardiol; 2015 Sep; 116(6):894-9. PubMed ID: 26189708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arrhythmogenic hereditary syndromes: Brugada Syndrome, long QT syndrome, short QT syndrome and CPVT.
    Schimpf R; Veltmann C; Wolpert C; Borggrefe M
    Minerva Cardioangiol; 2010 Dec; 58(6):623-36. PubMed ID: 21135804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium channelopathies: do we really understand what's going on?
    Postema PG; Mosterd A; Hofman N; Alders M; Wilde AA
    J Cardiovasc Electrophysiol; 2011 May; 22(5):590-3. PubMed ID: 20812931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ion Channel Disorders and Sudden Cardiac Death.
    Garcia-Elias A; Benito B
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic criteria for congenital long QT syndrome in the era of molecular genetics: do we need a scoring system?
    Hofman N; Wilde AA; Kääb S; van Langen IM; Tanck MW; Mannens MM; Hinterseer M; Beckmann BM; Tan HL
    Eur Heart J; 2007 Mar; 28(5):575-80. PubMed ID: 17090615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced fatal arrhythmias: Acquired long QT and Brugada syndromes.
    Turker I; Ai T; Itoh H; Horie M
    Pharmacol Ther; 2017 Aug; 176():48-59. PubMed ID: 28527921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Channelopathies: a new category of diseases causing sudden death.
    Brugada J; Brugada R; Brugada P
    Herz; 2007 May; 32(3):185-91. PubMed ID: 17497250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical heterogeneity in sodium channelopathies. What is the meaning of carrying a genetic mutation?
    Oliva A; Bjerregaard P; Hong K; Evans S; Vernooy K; McCormack J; Brugada J; Brugada P; Pascali VL; Brugada R
    Cardiology; 2008; 110(2):116-22. PubMed ID: 17971661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is It Safe for Patients With Cardiac Channelopathies to Undergo Routine Dental Care? Experience From a Single-Center Study.
    Oliveira ACG; Neves ILI; Sacilotto L; Olivetti NQS; Santos-Paul MAD; Montano TCP; Carvalho CMA; Wu TC; Grupi CJ; Barbosa SA; Pastore CA; Samesima N; Hachul DT; Scanavacca MI; Neves RS; Darrieux FCC
    J Am Heart Assoc; 2019 Aug; 8(15):e012361. PubMed ID: 31319747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of ventricular arrhythmias in suspected channelopathies.
    Obeyesekere MN; Antzelevitch C; Krahn AD
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):221-31. PubMed ID: 25691556
    [No Abstract]   [Full Text] [Related]  

  • 17. Triggers for arrhythmogenesis in the Brugada and long QT 3 syndromes.
    Peters CH; Abdelsayed M; Ruben PC
    Prog Biophys Mol Biol; 2016 Jan; 120(1-3):77-88. PubMed ID: 26713557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inherited Cardiac Arrhythmia Syndromes: Focus on Molecular Mechanisms Underlying TRPM4 Channelopathies.
    Amarouch MY; El Hilaly J
    Cardiovasc Ther; 2020; 2020():6615038. PubMed ID: 33381229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for, and management of, possible arrhythmogenic syndromes (channelopathies/ion channel diseases).
    Svendsen JH; Geelen P;
    Europace; 2010 May; 12(5):741-2. PubMed ID: 20421225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual phenotypic transmission in Brugada syndrome.
    Hermida JS; Arnalsteen-Dassonvalle E; Kubala M; Mathiron A; Traulle S; Anbazhagan K; Hermida A; Rochette J
    Arch Cardiovasc Dis; 2013; 106(6-7):366-72. PubMed ID: 23810369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.